AUDUBON, Pa., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full yea
AUDUBON, Pa., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year

Edwards Lifesciences (EW) Lags Q4 Earnings and Revenue Estimates

10:55pm, Wednesday, 26'th Jan 2022 Zacks Investment Research
Edwards Lifesciences (EW) delivered earnings and revenue surprises of -7.27% and 1.03%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
UBS is maintaining its buy rating on Globus Medical citing a survey of spine and neurosurgeons indicating it is poised to gain the most market share among competitors.

Encompass Health (EHC) to Spin Off Home Health & Hospice Unit

04:26pm, Thursday, 20'th Jan 2022 Zacks Investment Research
Encompass Health (EHC) expects the Enhabit Home Health & Hospice spinoff to be completed in first-half 2022.

Ensign Group (ENSG) Up 7.4% in 3 Months: More Growth Ahead?

04:56pm, Wednesday, 19'th Jan 2022 Zacks Investment Research
Ensign Group (ENSG) is likely to keep growing on the back of Skilled services and impressive financial strength.

Molina Healthcare (MOH) Up 14.4% in 6 Months: Growth Ahead?

03:19pm, Tuesday, 18'th Jan 2022 Zacks Investment Research
Molina Healthcare (MOH) is likely to keep growing on the back of increasing membership and higher premium revenues.

Ford Motor and IRobot have been highlighted as Zacks Bull and Bear of the Day

02:04pm, Friday, 07'th Jan 2022 Zacks Investment Research
Ford Motor and IRobot have been highlighted as Zacks Bull and Bear of the Day

Omicron Hits Elective MedTechs, 3 Subsectors Likely to Thrive

03:21pm, Thursday, 06'th Jan 2022 Zacks Investment Research
Here we discuss three major subsectors of MedTech and three constituent stocks, OPCH, GMED and OMCL for which the change in the scenario has opened up enormous growth prospects.
Here we discuss three major subsectors of MedTech and three constituent stocks, OPCH, GMED and OMCL for which the change in the scenario has opened up enormous growth prospects.

Here's Why You Should Hold on to Globus Medical (GMED) for Now

01:11pm, Monday, 03'rd Jan 2022 Zacks Investment Research
Investors are optimistic about Globus Medical (GMED), backed by strength in the Enabling Technologies arm and ExcelsiusGPS platforms.
Investors are optimistic about Globus Medical (GMED), backed by strength in the Enabling Technologies arm and ExcelsiusGPS platforms.
Globus Medical, Inc. - Analysts at Truist Securiti increased their FY2022 earnings estimates for Globus Medical in a report issued on Tuesday, December 21st. Truist Securiti…

M&T Bank Corp Purchases 1,113 Shares of Globus Medical, Inc. (NYSE:GMED)

10:06am, Wednesday, 22'nd Dec 2021 Transcript Daily
M&T Bank Corp lifted its position in Globus Medical, Inc. (NYSE:GMED) by 3.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,880 shares of the medical device companys stock after acquiring an additional 1,113 shares during the quarter. M&T Bank []

Is Globus Medical a Great Stock to Buy Right Now?

10:37pm, Thursday, 16'th Dec 2021 The Motley Fool
International sales were down in the most recent quarter.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE